Kodiak Sciences Inc. (KOD)
$37.22-$1.90 (-4.86%) Today
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's proprietary ABC platform. Another investigational medicine, KSI-501, is an anti-interleukin 6, or IL-6, VEGF-trap bispecific therapy built on the ABC platform and is being developed for high-prevalence retinal vascular diseases and intended to address the unmet needs of extended durability and targeting disease biology beyond VEGF for differentiated efficacy. Its third investigational medicine, KSI-101, is a high-strength (100 mg/mL) bispecific protein targeting IL-6 and VEGF.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 30,000 | $1.02M |
| Grant or award | 9 | 290,617 | |
| Option exercise | 2 | 60,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
22 Form 4 filings on record, the earliest from Jun 30, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John A. Borgeson - Officer | Grant or award | Stock Option (Right to Buy) | 66,500 | $0.00 | - | |
 Victor Perlroth - Officer | Grant or award | Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
 Taiyin Yang | Grant or award | Stock Option (Right to Buy) | 17,731 | $0.00 | - | |
| Robert Profusek | Grant or award | Stock Option (Right to Buy) | 17,731 | $0.00 | - | |
| Richard S. Levy | Grant or award | Stock Option (Right to Buy) | 17,731 | $0.00 | - | |
 Bassil I. Dahiyat | Grant or award | Stock Option (Right to Buy) | 17,731 | $0.00 | - | |
 Charles A. Bancroft | Grant or award | Stock Option (Right to Buy) | 17,731 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non-Qualified Stock Options (right to buy) | 17,731 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non-Qualified Stock Options (right to buy) | 17,731 | $0.00 | - | |
| John A. Borgeson - Officer | Option exercise | Common Stock | 30,000 | $1.04 | $31K | |
| John A. Borgeson - Officer | Open-market sale | Common Stock | 25,896 | $34.01 | $881K | |
| John A. Borgeson - Officer | Open-market sale | Common Stock | 4,104 | $34.67 | $142K | |
| John A. Borgeson - Officer | Option exercise | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| John A. Borgeson - Officer | Option exercise | Common Stock | 28,614 | $1.04 | $30K | |
| John A. Borgeson - Officer | Option exercise | Stock Option (Right to Buy) | 28,614 | $0.00 | - | |
| John A. Borgeson - Officer | Option exercise | Common Stock | 30,000 | $1.04 | $31K | |
| John A. Borgeson - Officer | Open-market sale | Common Stock | 12,692 | $39.14 | $497K | |
| John A. Borgeson - Officer | Open-market sale | Common Stock | 12,477 | $40.29 | $503K | |
| John A. Borgeson - Officer | Open-market sale | Common Stock | 4,231 | $40.88 | $173K | |
| John A. Borgeson - Officer | Open-market sale | Common Stock | 600 | $41.77 | $25K | |
| John A. Borgeson - Officer | Option exercise | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Victor Perlroth - Officer | Option exercise | Common Stock | 300,000 | $1.04 | $312K | |
| Victor Perlroth - Officer | Option exercise | Stock Option (Right to Buy) | 300,000 | $0.00 | - | |
| Victor Perlroth - Officer | Grant or award | Stock Option (Right to Buy) | 175,000 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Open-market purchase | Common Stock | 217,428 | $23.00 | $5.00M | |
| BAKER BROS. ADVISORS LP | Open-market purchase | Common Stock | 2,391,268 | $23.00 | $55.00M | |
| Victor Perlroth - Officer | Grant or award | Stock Option (Right to Buy) | 340,000 | $0.00 | - | |
| John A. Borgeson - Officer | Grant or award | Stock Option (Right to Buy) | 250,000 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non- Qualified Stock Options (right to buy) | 40,000 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non- Qualified Stock Options (right to buy) | 40,000 | $0.00 | - | |
| Richard S. Levy | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Bassil I. Dahiyat | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Charles A. Bancroft | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Taiyin Yang | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Robert Profusek | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
Kodiak Sciences Inc. (KOD) had 9 insider filings in the last 90 days, with the most recent on 2026-07-17. The full record for KOD runs to 22 Form 4 filings, the earliest from 2025-06-30. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of KOD were filed in the last 90 days. 2 purchases are on record for this company.
2 insider sales of KOD were filed in the last 90 days, totaling $1.02M.
This page tracks KOD Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add KOD to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
